BMRN

BIOMARIN PHARMACEUTICAL INC

Healthcare | Large Cap

-$0.25

EPS Forecast

$1,049

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

-$0.25

Revenue Forecast:

$1,049

EPS Surprise Forecast:

$0.046

Revenue Surprise Forecast:

$22

Post-release price volatility - Medium

Post-release Overnight Move:

±6.5%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

73%

Probability of beating revenue consensus:

86%

Probability of beating both EPS & revs consensus:

67%

Probability of missing both EPS & revs consensus:

7%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

1

Beta (β)

Forward Looking Beta (β):

0.41

Earnings volatility

EPS standard deviation:

$0.19

Revenue standard deviation:

$37

As % of share price:

0.35% MEDIUM

As % of market cap:

0.35% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$0.01

Revenue 95th %ile:

$1,100

EPS 75th %ile:

-$0.19

Revenue 75th %ile:

$1,063

EPS 25th %ile:

-$0.31

Revenue 25th %ile:

$1,037

EPS 5th %ile:

-$0.45

Revenue 5th %ile:

$1,007

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

43% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

43% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$8

Bid-ask per Share:

$0.045